Z223-2027 is a FcRn inhibitor. Z223-2027 competitively blocks the binding of immunoglobulin G ( IgG ) to FcRn . Z223-2027 can be used in the research of IgG-mediated autoimmune diseases.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Fc Receptor (FcR)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.